Understanding the Different Types of Patents: A Comprehensive Guide

Not every invention is the same – and neither is the patent that protects it. A groundbreaking new drug molecule, a smarter version of an existing device, or a clever new application for an old compound all require different kinds of legal protection. India’s patent system, governed by the Patents Act, 1970, recognizes this reality and provides distinct patent categories to match. Understanding these categories is not just an academic exercise – it is a foundational skill for anyone working in IP law, pharmaceuticals, technology, or business strategy.

What is a standard patent? 🔗

A standard patent – often simply called a “patent” or “utility patent” – is the most common form of patent protection available in India. It protects new inventions that offer a technical solution to a problem. To qualify, an invention must satisfy three core criteria under the Patents Act, 1970: novelty (it must be new), an inventive step (it must not be obvious to a person skilled in the relevant field), and industrial applicability (it must be capable of practical use in any industry).

Standard patents in India cover a broad range of subject matter – machines, devices, manufacturing processes, chemical compounds, and pharmaceutical formulations, among others. Once granted, a standard patent provides its holder with exclusive rights for 20 years from the date of filing, subject to payment of annual renewal fees. The Indian Patent Office, functioning under the Controller General of Patents, Designs and Trade Marks, is the authority responsible for examining and granting these patents.

In practical terms, standard patents are the backbone of innovation protection. A pharmaceutical company securing a patent on a new drug molecule, an electronics firm protecting a novel circuit design, or a startup patenting a new manufacturing process – all of these rely on the standard patent framework. It is the default choice when an inventor has created something genuinely new and wishes to obtain the broadest possible scope of protection.

Patent of addition: protecting improvements to existing inventions 🔗

Inventions rarely emerge fully formed. More often, an inventor files a patent for a product or process, and then – while the application is still pending or after the patent is granted – develops a meaningful improvement to that same invention. The patent of addition is the legal mechanism designed precisely for this scenario.

Section 54 of the Patents Act, 1970 allows an applicant or patentee to file for a patent of addition in respect of any improvement or modification of an invention already described in the complete specification of a pending or granted patent. The improvement must be genuinely new – it cannot be a mere workshop modification or an obvious tweak. Critically, the patent of addition does not require payment of a separate renewal fee; it remains valid for as long as the main (parent) patent remains in force, and expires along with it.

Consider this scenario: a startup files a standard patent for an electric vehicle battery that achieves a particular charge cycle. Six months later, while the application is being examined, the team develops a new electrode configuration that doubles battery life. Instead of filing an entirely new patent application – which would require meeting all patentability requirements independently and paying separate renewal fees – they can file a patent of addition. This addition builds on the original and is examined in relation to it. The parent patent’s grant is a precondition: a patent of addition will only be granted if the main patent is also granted.

The strategic value of the patent of addition lies in its cost-efficiency and its ability to extend the scope of protection over time without the burden of independent patentability. It incentivizes inventors to disclose and protect incremental progress – which, in many fields, is where most real-world innovation actually happens.

Utility model patents: a second-tier system India does not yet have 🔗

In many countries, there exists a category of IP protection designed specifically for inventions that are functional and novel but may not clear the relatively high bar of the “inventive step” requirement demanded by standard patents. These are called utility model patents – sometimes referred to as “petty patents” or “innovation patents.”

Utility model patents operate as a second-tier IP system. They typically require only a novelty check, not a full assessment of non-obviousness. The registration process is faster and less expensive, and the protection period is shorter – usually 7 to 10 years – compared to the 20-year term of standard patents. Approximately 75 countries, including Germany, China, Japan, and Brazil, have adopted some form of utility model protection.

Why utility models matter for small innovators 🔗

The typical beneficiary of a utility model system is not a large research-based corporation, but a small or medium-sized enterprise (SME), a local artisan, or a grassroots inventor. These actors often engage in what is called incremental innovation – adapting and improving existing technologies to suit local needs. Their inventions may not involve a dramatic inventive leap, but they are still new, useful, and deserving of protection. Without a utility model system, many such innovations fall through the cracks: too incremental for a standard patent, yet valuable enough to be commercially exploited by others.

India currently does not have a utility model protection system. The country’s patent framework recognizes only standard patents (and design protection under the Designs Act, 2000). This creates a gap, particularly for India’s large informal sector and its millions of small businesses that produce incremental innovations without the resources to invest in full patent prosecution. Discussions around introducing utility model protection for India have been ongoing in IP policy circles, and it remains an area to watch as the country develops its innovation ecosystem.

New use patents: when a known substance finds a new purpose 🔗

The concept of a new use patent addresses a specific and commercially significant question: can an inventor patent a newly discovered application of an already-known compound or product? In principle, yes – but in India, this category is hedged with important restrictions, particularly in the pharmaceutical sector.

A new use patent would cover, for example, discovering that a compound already known as a treatment for condition A is also effective against condition B. The compound itself is not new, but the use is. In many jurisdictions, this qualifies as a patentable invention because it adds genuine value and requires research and development effort to uncover.

The Section 3(d) barrier in Indian pharmaceutical patents 🔗

India’s approach to new use claims in pharmaceuticals is shaped significantly by Section 3(d) of the Patents Act, 1970. This provision – one of the most discussed clauses in Indian IP law – bars patentability of a “mere discovery of any new property or new use for a known substance” unless the new form demonstrates a significantly enhanced efficacy compared to the original. In other words, discovering that a drug works for a new disease is not enough on its own; the applicant must demonstrate a meaningful improvement in therapeutic outcome.

Section 3(d) was introduced specifically to prevent a practice known as “evergreening” – where pharmaceutical companies make minor modifications to existing drugs (changing the salt form, dosage, or formulation) and file new patents to extend their market exclusivity well beyond the original patent term. This practice delays the entry of affordable generic medicines into the market and keeps drug prices high – a serious concern in a country where access to affordable healthcare is a national priority.

The landmark case that defined how Section 3(d) works in practice is Novartis AG v. Union of India (2013). Novartis sought a patent for the beta crystalline form of Imatinib Mesylate – the active ingredient in the cancer drug Glivec. The Supreme Court of India rejected the application, holding that the new form did not demonstrate enhanced therapeutic efficacy over the already-known substance. The Court clarified that for pharmaceutical patents, “efficacy” means therapeutic efficacy – improved clinical outcomes in patients – not merely improved physicochemical properties like better solubility or bioavailability, unless those properties directly translate into better treatment results.

Strategic relevance of new use patents outside pharmaceuticals 🔗

Outside the pharmaceutical domain, new use patents face fewer structural barriers in India, provided the general requirements of novelty, inventive step, and industrial applicability are met. However, the pharmaceutical context remains the most commercially significant and the most legally contested. Companies in this space must structure their research documentation carefully, generate clinical data to support efficacy claims, and anticipate Section 3(d) objections from the Indian Patent Office from the earliest stages of patent prosecution.

Comparing the types: a strategic overview 🔗

Each type of patent serves a distinct purpose, and understanding how to deploy them strategically is as important as understanding the law behind them. Standard patents are the go-to choice for core innovations – new products, processes, or formulations that clear all patentability thresholds. Patents of addition are the right tool when an inventor wants to protect improvements to an existing patent without paying separate renewal fees or meeting independent patentability standards. Utility model patents, while not yet available in India, represent a gap in the system that SMEs and grassroots innovators feel acutely. And new use patents require careful navigation, especially in the life sciences, where Section 3(d) creates a uniquely high threshold and demands proof of real-world therapeutic improvement.

In competitive industries, patent strategy often goes beyond filing a single application. Companies build what are sometimes called “patent portfolios” – layered networks of standard patents, patents of addition, and (where available) other patent types that together create comprehensive protection for their technology. Understanding which type of patent fits which innovation is the first step in building a sound IP strategy. For students and practitioners of law, it is also the foundation on which all further learning about patent prosecution, licensing, and enforcement is built.

India’s patent regime continues to evolve. The ongoing debate over introducing utility model protection, the government’s firm stance on preventing evergreening through Section 3(d), and the country’s growing status as a global innovation hub all point to a system in active development. Staying current with these changes is not optional for anyone working in this field – it is essential.

What do you think? Should India introduce a utility model patent system to help small businesses and grassroots innovators protect incremental innovations that currently fall outside the standard patent threshold? And does India’s Section 3(d) strike the right balance between preventing pharmaceutical evergreening and encouraging genuine new-use research in the life sciences?

References

1. https://ipindia.gov.in/acts-patents.htm
2. https://razorpay.com/learn/types-of-patents/
3. https://acuraip.com/types-of-patent-applications-in-india/
4. https://www.legalwiz.in/blog/know-all-about-different-types-of-patents
5. https://blog.ipleaders.in/the-concept-of-utility-model-patent/
6. https://www.globalpatentfiling.com/blog/concept-utility-model-patent-in-india-under-patent-law-with-example
7. https://thelegalschool.in/blog/indian-patent-law-section-3d
8. https://www.rkdewan.com/blogs/evergreening-patents-in-india-legal-precedents-pharma-sector/
9. https://www.lexology.com/library/detail.aspx?g=3b0a7755-be04-4296-8b73-d90cb0afeb50
10. https://www.globaljurix.com/law-news/evergreening-would-not-be-allowed-india-defends-section-3-d-of-patent-act.php